Fabrication and Evaluation of Pluripotent Stem Cells Expressing in Human iPS Cells as In-vitro Model

Our latest report details the production of human induced pluripotent stem cells (iPSC) master cell banks (MCB) that are produced by a therapeutically compliant approach that starts with cord blood. The two iPSC clones created by this method were thoroughly characterised in this publication, utilising whole genome sequencing (WGS), microarray, and comparative genomic hybridization (aCGH) single nucleotide polymorphism (SNP) analysis. We compare these profiles with lines created by a similar procedure from different donors, a reporter subclone, and a suggested calibration material. We think it is likely that several clinical products will be made using iPSCs. Furthermore, given their immortal state, we anticipate that the lines utilised as input material will be used for many years or even decades at various sites. As a result, assay development will be crucial to tracking the condition of the cells and their drift within the culture. We propose that a thorough description of the cells' starting state, a comparison with some calibration data, and the creation of reporter sublcones will aid in identifying the most beneficial set of tests for keeping an eye on the cells and defining standards for eliminating a line